Tepnel to raise 5m pounds in USM launch
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.TEPNEL Diagnostics, a greenfield company developing a new product for detecting the Aids virus, is to be launched on the Unlisted Securities Market later this month.
The flotation is aimed at raising about pounds 5m via a share placing to fund its product development plans and will value the company at about pounds 25m on launch.
Tepnel is involved in medical diagnostics aimed at detecting contamination of food products as well as in blood, including HIV, the virus that leads to Aids.
Proceeds from the flotation are to be used for the commercial development of its disposable testing equipment for use by the food and medical industry. Much of the company's early research has already been completed but its products require further work before they can be marketed.
Although the company has yet to receive firm orders it believes there is a huge potential demand for its diagnostics devices.
Tepnel's development stems from a scientific breakthrough by researchers at the University of Manchester seven years ago. Since then the scientists have been funding their research partly with private investors.
The flotation is the latest of several medical research companies launched by Allied Provincial in the past few years. Its previous flotations in the sector include ML Laboratories, Haemocell and Proteus.
The broker has been actively marketing Tepnel to City institutions in the past few days. The launch is understood to have generated considerable interest from potential investors.
Earlier this year British Biotechnology joined the stock market via a pounds 152m flotation.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments